Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231

por Garbar, Christian, Mascaux, Corinne, Giustiniani, Jérôme, Merrouche, Yacine, Bensussan, Armand
Publicado 2017

The Interleukin-17 Family of Cytokines in Breast Cancer

por Fabre, Joseph Antoine Salvator, Giustiniani, Jérôme, Garbar, Christian, Merrouche, Yacine, Antonicelli, Frank, Bensussan, Armand
Publicado 2018

Cytotoxic activity of peripheral blood mononuclear cells in patients with endometriosis: A cross-sectional study

por Muharam, Raden, Bustami, Arleni, Gusti Mansur, Indra, Zulkifli Jacoeb, Teuku, Giustiniani, Jerome, Schiavon, Valerie, Bensussan, Armand
Publicado 2022

Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type

por Fabre, Joseph, Giustiniani, Jerome, Garbar, Christian, Antonicelli, Frank, Merrouche, Yacine, Bensussan, Armand, Bagot, Martine, al-Dacak, Reem
Publicado 2016

IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells

por Merrouche, Yacine, Fabre, Joseph, Cure, Herve, Garbar, Christian, Fuselier, Camille, Bastid, Jeremy, Antonicelli, Frank, Al-Daccak, Reem, Bensussan, Armand, Giustiniani, Jerome
Publicado 2016

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma

por Gauci, Marie-Léa, Giustiniani, Jérôme, Lepelletier, Clémence, Garbar, Christian, Thonnart, Nicolas, Dumaz, Nicolas, Foussat, Arnaud, Lebbé, Céleste, Bensussan, Armand, Marie-Cardine, Anne
Publicado 2022

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

por Plée, Julie, Le Jan, Sébastien, Giustiniani, Jérôme, Barbe, Coralie, Joly, Pascal, Bedane, Christophe, Vabres, Pierre, Truchetet, François, Aubin, François, Antonicelli, Frank, Bernard, Philippe
Publicado 2015

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells

por Mombelli, Sarah, Cochaud, Stéphanie, Merrouche, Yacine, Garbar, Christian, Antonicelli, Frank, Laprevotte, Emilie, Alberici, Gilles, Bonnefoy, Nathalie, Eliaou, Jean-François, Bastid, Jérémy, Bensussan, Armand, Giustiniani, Jérôme
Publicado 2015

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

por Cochaud, Stéphanie, Giustiniani, Jérôme, Thomas, Clémence, Laprevotte, Emilie, Garbar, Christian, Savoye, Aude-Marie, Curé, Hervé, Mascaux, Corinne, Alberici, Gilles, Bonnefoy, Nathalie, Eliaou, Jean-François, Bensussan, Armand, Bastid, Jeremy
Publicado 2013

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

por Hocine, Hocine R., Costa, Hicham El, Dam, Noemie, Giustiniani, Jerome, Palacios, Itziar, Loiseau, Pascale, Bensussan, Armand, Borlado, Luis R., Charron, Dominique, Suberbielle, Caroline, Jabrane-Ferrat, Nabila, Al-Daccak, Reem
Publicado 2017

Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

por Hocine, Hocine R., Costa, Hicham E. L., Dam, Noemie, Giustiniani, Jerome, Palacios, Itziar, Loiseau, Pascale, Benssusan, Armand, Borlado, Luis R., Charron, Dominique, Suberbielle, Caroline, Jabrane-Ferrat, Nabila, Al-Daccak, Reem
Publicado 2017

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

por Hocine, Hocine R., Costa, Hicham E. L., Dam, Noemie, Giustiniani, Jerome, Palacios, Itziar, Loiseau, Pascale, Bensussan, Armand, Borlado, Luis R., Charron, Dominique, Suberbielle, Caroline, Jabrane-Ferrat, Nabila, Al-Daccak, Reem
Publicado 2017

Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit

por Hocine, Hocine Rachid, Brunel, Simon, Chen, Qian, Giustiniani, Jerome, San Roman, Mabel Jouve, Ferrat, Yann J., Palacios, Itziar, de la Rosa, Olga, Lombardo, Eleuterio, Bensussan, Armand, Charron, Dominique, Jabrane‐Ferrat, Nabila, Al‐Daccak, Reem
Publicado 2019

CCR8 is a new therapeutic target in cutaneous T-cell lymphomas

por Giustiniani, Jérôme, Dobos, Gabor, Moins-Teisserenc, Hélène, Eustaquio, Tiago, Battistella, Maxime, Ortonne, Nicolas, Ram-Wolff, Caroline, Bouaziz, Jean-David, Marie-Cardine, Anne, Mourah, Samia, Bagot, Martine, Kupper, Thomas S., Clark, Rachael A., Bensussan, Armand, de Masson, Adèle
Publicado 2022

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway

por Laprevotte, Emilie, Cochaud, Stéphanie, du Manoir, Stanislas, Lapierre, Marion, Dejou, Cécile, Philippe, Marion, Giustiniani, Jérome, Frewer, Kathryn A., Sanders, Andrew J., Jiang, Wen G., Michaud, Henri-Alexandre, Colombo, Pierre-Emmanuel, Bensussan, Armand, Alberici, Gilles, Bastid, Jérémy, Eliaou, Jean-François, Bonnefoy, Nathalie
Publicado 2017

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma

por Decroos, Amandine, Cheminant, Morgane, Bruneau, Julie, Carras, Sylvain, Parinet, Vincent, Pelletier, Laura, Lacroix, Laetitia, Martin, Nadine, Giustiniani, Jérôme, Lhermitte, Ludovic, Asnafi, Vahid, Battistella, Maxime, Lemonnier, François, de Leval, Laurence, Sicard, Hélène, Bonnafous, Cécile, Gauthier, Laurent, Genestier, Laurent, Caruso, Stefano, Gaulard, Philippe, Hermine, Olivier, Ortonne, Nicolas
Publicado 2023

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

por Chabot, Sophie, Jabrane-Ferrat, Nabila, Bigot, Karine, Tabiasco, Julie, Provost, Alexandra, Golzio, Muriel, Noman, Muhammad Zaeem, Giustiniani, Jérôme, Bellard, Elisabeth, Brayer, Stéphanie, Aguerre-Girr, Maryse, Meggetto, Fabienne, Giuriato, Sylvie, Malecaze, François, Galiacy, Stéphane, Jaïs, Jean-Philippe, Chose, Olivier, Kadouche, Jean, Chouaib, Salem, Teissié, Justin, Abitbol, Marc, Bensussan, Armand, Le Bouteiller, Philippe
Publicado 2011